Engimmune Therapeutics

ImmunoScape

This biotechnology company develops T-cell receptor immunotherapies and immune profiling platforms for pharmaceutical firms and academic researchers to treat solid tumours.

3T Biosciences

The company develops T-cell receptor therapeutics and target identification technologies for oncology patients to treat solid tumours.

GC Therapeutics

This deep-tech company develops a cell programming platform to produce off-the-shelf medicines for patients with gastrointestinal, neurological and immunological diseases.

Arsenal Biosciences, Inc. (ArsenalBio)

This deep-tech company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.

Ouro Medicines

This biotechnology firm develops T-cell engager therapies to treat patients living with chronic immune-mediated diseases.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

Immunocore

This biotechnology company develops T cell receptor immunotherapies to treat patients with cancer, infectious diseases and autoimmune conditions.

Captain T Cell

The company develops cell therapies for cancer patients to treat solid tumours.